| Efficacy and safety of oral alitretinoin (9‐cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized … T Ruzicka, CW Lynde, GBE Jemec, T Diepgen, J Berth‐Jones, ... British Journal of Dermatology 158 (4), 808-817, 2008 | 429 | 2008 |
| Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial A Vaclavkova, S Chimenti, P Arenberger, P Holló, PG Sator, M Burcklen, ... The Lancet 384 (9959), 2036-2045, 2014 | 150 | 2014 |
| Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary E Herédi, F Rencz, O Balogh, L Gulácsi, K Herszényi, P Holló, H Jókai, ... The European Journal of Health Economics 15, 111-119, 2014 | 95 | 2014 |
| Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study H Jókai, J Szakonyi, O Kontár, M Marschalkó, K Szalai, S Kárpáti, P Holló Journal of the American Academy of Dermatology 69 (4), 523-529, 2013 | 93 | 2013 |
| A detailed analysis of ‘not relevant’responses on the DLQI in psoriasis: potential biases in treatment decisions F Rencz, AK Poór, M Péntek, P Holló, S Kárpáti, L Gulácsi, A Szegedi, ... Journal of the European Academy of Dermatology and Venereology 32 (5), 783-790, 2018 | 64 | 2018 |
| Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients AK Poór, F Rencz, V Brodszky, L Gulácsi, Z Beretzky, B Hidvégi, P Holló, ... Quality of Life Research 26, 3409-3419, 2017 | 64 | 2017 |
| Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis F Rencz, L Gulácsi, M Péntek, AK Poór, M Sárdy, P Holló, A Szegedi, ... British Journal of Dermatology 179 (5), 1102-1108, 2018 | 61 | 2018 |
| Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T‐cell‐mediated skin diseases M Ferran, ER Romeu, C Rincón, M Sagristà, AM Giménez Arnau, ... Experimental Dermatology 22 (7), 439-442, 2013 | 56 | 2013 |
| Streptococcus pyogenes–induced cutaneous lymphocyte antigen–positive T cell–dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis E Ruiz-Romeu, M Ferran, M Sagristà, J Gómez, A Giménez-Arnau, ... Journal of Allergy and Clinical Immunology 138 (2), 491-499. e6, 2016 | 53 | 2016 |
| Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres O Balogh, V Brodszky, L Gulácsi, E Herédi, K Herszényi, H Jókai, ... The European Journal of Health Economics 15, 101-109, 2014 | 48 | 2014 |
| Is the DLQI appropriate for medical decision-making in psoriasis patients? AK Poór, V Brodszky, M Péntek, L Gulácsi, G Ruzsa, B Hidvégi, P Holló, ... Archives of Dermatological Research 310, 47-55, 2018 | 45 | 2018 |
| Successful treatment of lichen planus with adalimumab. P Holló, J Szakonyi, D Kiss, H Jokai, A Horváth, S Kárpáti Acta dermato-venereologica 92 (4), 2012 | 42 | 2012 |
| Angiolymphoid hyperplasia with eosinophilia in pregnancy P Hollo J Eur Acad Dermatol Venereol 19, 645-646, 2005 | 39 | 2005 |
| Long-term drug survival and predictor analysis of the whole psoriatic patient population on biological therapy in Hungary L Pogácsás, A Borsi, P Takács, É Remenyik, L Kemény, S Kárpáti, P Holló, ... Journal of Dermatological Treatment 28 (7), 635-641, 2017 | 36 | 2017 |
| DLQI‐R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea F Rencz, L Gulácsi, M Péntek, A Szegedi, É Remenyik, Z Bata‐Csörgő, ... British Journal of Dermatology 182 (5), 1167-1175, 2020 | 32 | 2020 |
| Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity F Rencz, P Holló, S Kárpáti, M Péntek, É Remenyik, A Szegedi, O Balogh, ... Journal of the European Academy of Dermatology and Venereology 29 (7), 1398-1405, 2015 | 31 | 2015 |
| Diffusion-based data augmentation for skin disease classification: Impact across original medical datasets to fully synthetic images M Akrout, B Gyepesi, P Holló, A Poór, B Kincső, S Solis, K Cirone, ... International Conference on Medical Image Computing and Computer-Assisted …, 2023 | 26 | 2023 |
| Microbe-dependent induction of IL-9 by CLA+ T cells in psoriasis and relationship with IL-17A E Ruiz-Romeu, M Ferran, C de Jesús-Gil, P García, M Sagristà, ... Journal of Investigative Dermatology 138 (3), 580-587, 2018 | 25 | 2018 |
| Disease burden of psoriasis associated with psoriatic arthritis in Hungary F Rencz, V Brodszky, M Péntek, O Balogh, É Remenyik, A Szegedi, ... Orvosi Hetilap 155 (48), 1913-1921, 2014 | 25 | 2014 |
| Time to revise the Dermatology Life Quality Index scoring in psoriasis treatment guidelines F Rencz, V Brodszky, L Gulácsi, M Péntek, AK Poór, P Holló, A Szegedi, ... Journal of the European Academy of Dermatology and Venereology: JEADV 33 (7 …, 2019 | 24 | 2019 |
